Brief: HOOKIPA Pharma Reports First Quarter 2022 Financial Results, Recent Highlights
May 16 (Reuters) - HOOKIPA Pharma Inc HOOK.O :
* HOOKIPA PHARMA REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND
RECENT HIGHLIGHTS
* HOOKIPA'S CASH, CASH EQUIVALENTS AND RESTRICTED CASH AS OF
MARCH
31, 2022 WAS $141.8 MILLION
* QTRLY LOSS PER SHARE $0.40
* Q1 EARNINGS PER SHARE VIEW $-0.24 -- REFINITIV IBES DATA
* HB-200 PROGRAM ON TRACK TO REPORT PHASE 1 DATA MID-YEAR,
PHASE 2
DATA IN COMBINATION WITH PEMBROLIZUMAB IN SECOND HALF OF 2022
Source text for Eikon: ID:nGNX6kZMHp
Further company coverage: HOOK.O
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)